Crossmark

Immunotherapy-mediated dermatological adverse events: the urgent need for a common, clinically meaningful, management strategy

Published Online: 2020-08-21

Published Print: 2020-12

Authors

Apalla, Zoe https://orcid.org/0000-0002-9255-8196
Sibaud, Vincent
License Information

Text and Data Mining valid from 2020-08-21

Version of Record valid from 2020-08-21
More Information

Article History

Received: 26 June 2020

Accepted: 19 August 2020

First Online: 21 August 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current